.Amgen has shared (PDF) the very first phase 3 information on its own $400 thousand eczema medicatio...
.Biogen and UCB's gamble on improving into phase 3 astride a failed research seeks to have paid, alo...
.Italian biotech Aptadir Rehabs has released along with the commitment that its pipe of preclinical ...
.Wave Life Sciences has actually met its goal in a Duchenne muscular dystrophy (DMD) research, placi...
.After a few years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma fold, using ...
.Achilles Therapeutics has actually torn up its own method. The British biotech is actually quiting ...
.Aligos Therapies is actually proclaiming a midstage win in metabolic-dysfunction connected steatohe...
.Basilea Pharmaceutica's job establishing brand new antifungals has actually received a significant ...
.Possessing actually scooped up the U.S. rights to Capricor Therapies' late-stage Duchenne muscle dy...
.After dismissing the selection date for Applied Therapeutics' metabolic disorder drug govorestat, t...